The Medtronic SynchroMed II System is an implantable device that delivers medications to specific parts of the body. These devices have been used by more than 200,000 patients around the world to treat those diagnosed with cancer, severe muscle spasticity, chronic pain, and many other disorders.
While the device has helped thousands of people get the medications they need, countless others have suffered adverse effects from problems with the pumps.
Since the Medtronic SynchroMed II device was first approved by the U.S. Food and Drug Administration in 2004, dozens of recalls have been issued over defects and issues with the devices. These range from battery power issues that have resulted in device failure to software problems that could cause the incorrect administration of doses.
After countless injuries and more than a dozen deaths, patients have started filing lawsuits against Medtronic.